Concepedia

Azher Hussain

AH

10

Publications

619

Citations

10

H-Index

2007

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Pfizer (United States)

Azher Hussain is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in autoimmunity, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2007–2022

10

Publications

10

Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors

Jeremy Lewin, Jean‐Charles Soria, Anastasios Stathis et al. · Journal of Clinical Oncology · 2018 · 267 citations

Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species

Huadong Tang, Azher Hussain, Mauricio Leal et al. · Drug Metabolism and Disposition · 2007 · 136 citations

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough

David Muccino, Alyn H. Morice, Surinder S. Birring et al. · ERJ Open Research · 2020 · 53 citations · Full text

The effect of the neonatal Fc receptor on human IgG biodistribution in mice

Nancy Chen, Weirong Wang, Scott Fauty et al. · mAbs · 2014 · 51 citations · Full text

Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis

Sauzanne Khalilieh, Azher Hussain, Diana Montgomery et al. · British Journal of Clinical Pharmacology · 2018 · 33 citations · Full text

Rows per page

1–5 of 10